Efficacy and safety of LABA/LAMA fixed-dose combinations approved in the US for the management of COPD-Reference-Cited by-同舟云学术

Efficacy and safety of LABA/LAMA fixed-dose combinations approved in the US for the management of COPD

Published:2016-05-30 Issue:7 Volume:10 Page:767-780
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Banerji Donald¹,Mahler Donald A.²³,Hanania Nicola A.⁴

Affiliation:

1. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

2. Geisel School of Medicine at Dartmouth, Hanover, NH, USA

3. Valley Regional Hospital, Hanover, NH, USA

4. Section of Pulmonary and Critical Care Medicine, Asthma and COPD Clinical Research Center, Baylor College of Medicine, Houston, TX, USA

Funder

Novartis

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2016.1190276

Reference63 articles.

1. Global initiative for chronic Obstructive Lung Disease (GOLD 2014). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2015 [cited 2016 Feb 4]. Available from: www.goldcopdorg/uploads/users/files/GOLD_Report_2015pdf2015

2. Olodaterol: A Review of Its Use in Chronic Obstructive Pulmonary Disease

3. Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents

4. Ten years of tiotropium: clinical impact and patient perspectives

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incorporando nuevas evidencias sobre medicamentos inhalados en la EPOC. Asociación Latinoamericana de Tórax (ALAT) 2019;Archivos de Bronconeumología;2020-02

2. Incorporating new evidence on inhaled medications in COPD. The latin American chest association (ALAT) 2019;Archivos de Bronconeumología (English Edition);2020-02

3. Effects of baseline symptom burden on treatment response in COPD;International Journal of Chronic Obstructive Pulmonary Disease;2019-01

4. Cost-Effectiveness of Fixed-Dose Combinations Therapies for Chronic Obstructive Pulmonary Disease Treatment;Clinical Drug Investigation;2018-04-13

5. Baseline Symptom Score Impact on Benefits of Glycopyrrolate/Formoterol Metered Dose Inhaler in COPD;Chest;2017-12